Prognostic value of Ki67 index in gastrointestinal stromal tumors (Q33802994)

29 July 2017

title

Prognostic value of Ki67 index in gastrointestinal stromal tumors (English)

1 reference

29 July 2017

10

Hui Cao

1 reference

29 July 2017

3

Ming Wang

1 reference

29 July 2017

6

Chao-Jie Wang

1 reference

29 July 2017

8

Yan-Yin Shen

1 reference

29 July 2017

Wen-Yi Zhao

1

1 reference

29 July 2017

Jia Xu

2

1 reference

29 July 2017

Zi-Zhen Zhang

4

1 reference

29 July 2017

Lin Tu

5

1 reference

29 July 2017

Tian-Long Lin

7

1 reference

29 July 2017

Qiang Liu

9

1 reference

29 July 2017

publication date

15 April 2014

1 reference

International Journal of Clinical and Experimental Pathology

29 July 2017

published in

1 reference

29 July 2017

volume

7

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

2298-2304

1 reference

Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Ki67 and proliferation in breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Correlation between Ki67 and breast cancer prognosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Adjuvant therapy for high-risk gastrointestinal stromal tumour: considerations for optimal management

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Gastrointestinal stromal tumors (GISTs): a review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Ki-67 expression score correlates to survival rate in gastrointestinal stromal tumors (GIST)

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Exon 11 mutations, Ki67, and p16INK4A as predictors of prognosis in patients with GIST

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Epidemiology of gastrointestinal stromal tumours: Single-institution experience and clinical presentation over three decades

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Prognostic factors in gastrointestinal endocrine tumors

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069950

Diagnosis of gastrointestinal stromal tumors: A consensus approach

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24966939

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMC publication ID

4069950

1 reference

29 July 2017

1 reference